Predicate Device Removal May Trigger 510(k) Rescissions - Proposed Rule
This article was originally published in The Gray Sheet
Executive Summary
FDA's Center for Devices and Radiological Health may rescind 510(k) clearance for a device if its predicate is removed from the market "for safety or effectiveness reasons" by either FDA or the product's manufacturer, the agency states in a Jan. 16 proposed rule.
You may also be interested in...
Comments To FDA Suggest 510(k) Rescission Proposed Rule Needs Reworking
FDA's proposed rule on 510(k) rescission does not provide an acceptable framework for appealing rescission and is untenable as it is currently written, industry comments recently submitted to FDA suggest.
Comments To FDA Suggest 510(k) Rescission Proposed Rule Needs Reworking
FDA's proposed rule on 510(k) rescission does not provide an acceptable framework for appealing rescission and is untenable as it is currently written, industry comments recently submitted to FDA suggest.
MIS Execs Allegedly Defrauded FDA During Acquisition Talks With Medtronic
While Micro Interventional Systems was in discussions with Medtronic about a possible acquisition in November 1995, two executives at the Sunnyvale, California-based firm allegedly were falsifying data in various 510(k) submissions to FDA in an apparent attempt to impress Medtronic with the breadth of MIS' neurovascular product pipeline.